Novo Nordisk A/S(NONOF)

Research Snapshot

Novo Nordisk A/S (NONOF) is a Healthcare stock with a market cap of $1.24T and listed on OTC. The stock last traded around $47.56 and down 31.2% across the available one-year price window (Jun 30, 2025 → Jun 24, 2026). Baseline metrics include revenue growth of +6.2%, EPS growth of +1.4%, a dividend yield of 4.2%. What stands out right now is revenue +6.2%, EPS +1.4%, free cash flow -15.5% with operating margin 41.3% and ROIC 29.5%. The dividend matters to the case here, with a current yield around 4.2%. Valuation is more restrained than many high-expectation growth names at P/E 12.1 and price/sales 4.0. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines NONOF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.